Skip to main content

PerkinElmer Inks $200M Loan Agreement

NEW YORK (GenomeWeb) – PerkinElmer disclosed in a filing with the US Securities and Exchange Commission that has signed a $200 million loan agreement with JPMorgan Chase Bank.

The agreement was signed on Aug. 11 and has a term of 364 days. PerkinElmer has the option of getting funds as Eurocurrency Loans or ABR Loans, and the loans are repayable in full at maturity.

The firm said it may use the loans to finance its $1.3 billion acquisition of Euroimmun Medical Laboratory Diagnostics and for general corporate purposes.